Technical Analysis for IDXG - Interpace Diagnostics Group, Inc.

Grade Last Price % Change Price Change
grade F 0.93 -1.06% -0.01
IDXG closed down 1.06 percent on Friday, February 15, 2019, on 40 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical IDXG trend table...

Date Alert Name Type % Chg
Feb 15 20 DMA Resistance Bearish 0.00%
Feb 15 50 DMA Resistance Bearish 0.00%
Feb 14 Fell Below 20 DMA Bearish -1.06%
Feb 14 Fell Below 50 DMA Bearish -1.06%
Feb 14 180 Bearish Setup Bearish Swing Setup -1.06%
Feb 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.06%
Feb 14 Outside Day Range Expansion -1.06%
Feb 13 20 DMA Support Bullish -5.20%
Feb 13 50 DMA Support Bullish -5.20%
Feb 13 Inside Day Range Contraction -5.20%

Older signals for IDXG ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
PDI, Inc. provides outsourced commercial services to pharmaceutical, biotechnology, diagnostics, and healthcare companies in the United States. It operates in two segments, Commercial Services and Interpace Diagnostics. The Commercial Services segment offers outsourced sales teams that target healthcare providers, providing a range of complementary sales support services designed to achieve its customers' strategic and financial product objectives. This segment offers a range of personal and non-personal promotional options for the commercialization of their products throughout the product lifecycles, from development through maturity. It also provides other promotional services, including clinical educator, teledetailing, and full product commercialization services. This segment's services include product distribution, personal and non-personal product detailing, full supply chain management, operations, sales, marketing, compliance, and regulatory/medical management. The Interpace Diagnostics segment focuses on developing and commercializing molecular diagnostic tests for physicians and patients with diagnostic options for detecting genetic and other molecular alterations associated with gastrointestinal and endocrine cancers. This segment offers PancraGen, a diagnostic test designed for determining risk of malignancy in pancreatic cysts; and ThyGenX, a next-generation sequencing test designed to assist physicians in distinguishing between benign and malignant genotypes in indeterminate thyroid nodules. It also has three diagnostic tests in late stage development that are designed to detect genetic alterations that are associated with gastrointestinal cancers; and one diagnostic test in late stage development that is designed to detect genetic alterations that are associated with endocrine cancers. PDI, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
Biotechnology Cancer Healthcare Life Sciences Biology Supply Chain Management Healthcare Providers Medical Genetics Diagnostic Tests Qiagen
Is IDXG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.78
52 Week Low 0.7561
Average Volume 283,272
200-Day Moving Average 1.0943
50-Day Moving Average 0.9472
20-Day Moving Average 0.9408
10-Day Moving Average 0.9521
Average True Range 0.064
ADX 13.57
+DI 17.0479
-DI 18.833
Chandelier Exit (Long, 3 ATRs ) 0.928
Chandelier Exit (Short, 3 ATRs ) 0.9481
Upper Bollinger Band 1.041
Lower Bollinger Band 0.8406
Percent B (%b) 0.45
BandWidth 21.30102
MACD Line -0.0043
MACD Signal Line -0.0072
MACD Histogram 0.0029
Fundamentals Value
Market Cap 20.61 Million
Num Shares 22.2 Million
EPS -1.17
Price-to-Earnings (P/E) Ratio -0.79
Price-to-Sales 2.01
Price-to-Book 0.69
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.01
Resistance 3 (R3) 1.01 0.99 0.99
Resistance 2 (R2) 0.99 0.97 0.99 0.99
Resistance 1 (R1) 0.96 0.96 0.95 0.96 0.98
Pivot Point 0.94 0.94 0.94 0.94 0.94
Support 1 (S1) 0.91 0.92 0.90 0.91 0.88
Support 2 (S2) 0.89 0.91 0.89 0.87
Support 3 (S3) 0.86 0.89 0.87
Support 4 (S4) 0.86